The eugenicist of UNESCO
By Stefan Bernhardt-Radu,
Aeon
| 12. 02. 2024
Why did Julian S Huxley, first director of the UN agency, think eugenics held the key to a more evolved, harmonious world?
In the 18th century, European scholars began to envision a more enlightened world in harmony with nature. The old aristocratic regime, some hoped, would soon be replaced by a progressive society in which moral and social values were aligned with the natural and mechanical sciences. Aligning with nature, however, was not always a straightforward or positive process. In an enlightened world, human populations could not expand indefinitely. Resources would quickly become depleted by growing demand, which would slow progress and send humanity backward. That is why, at the end of the century, the British economist Thomas Malthus proposed that the growth of human populations needed to be kept in check. Like other species that were held in equilibrium with their environment, we should also find a balance between the supply of available resources and their demand. But if we failed to control our own populations, Malthus believed that war, famine or disease would do it for us. For humanity to advance, we needed hard limits.
Malthus’s ideas emerged at a time when Britain was being socially reconfigured. Rapid industrialisation and...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...